Our prospective study in the general population has helped clarify the role of GPR50 in mood disorders, by investigating the association between three commonly studied nonsynonymous variants and depression, comorbid depression and anxiety, as well as antidepressant use in the elderly. Here, GPR50 is linked to depressive symptom measurement.